In stock... For the Rapid Detection of group A streptococcal antigen (Strep A) from throat swab specimens.
The cardiac markers myoglobin, CK-MB, and troponin I have been established as useful tools in the diagnosis of acute myocardial infarction (AMI). Since the temporal release patterns of the three markers have significant differences, all three are useful tools in the determination of the source of chest pain. Cell injury from AMI has been shown to result in a level of blood myoglobin above the upper limit of normal in approximately 2-3 hours after the onset of chest pain. Maximum concentrations are generally observed after 9-12 hours. CK-MB and troponin I are found in blood at elevated concentrations approximately 4- 6 hours after the onset of chest pain and peak at 12-24 hours. However, whereas CK-MB levels return to normal values in about 72 hours, troponin I levels remain elevated for up to 14 days. The use of these three markers is therefore complementary as an aid in the diagnosis of AMI given the different release times and half-lives after myocardial infarction.
The ATFirst™ Cardiac 3/1 for the qualitative determination of cardiac myoglobin, CK-MB and troponin I in human serum, whole blood or plasma as an aid in the diagnosis of acute myocardial infarction in emergency room, critical care, point-of-care, or hospital settings. Measurement of cardiac myoglobin, CK-MB, and troponin I, aids in rapid diagnosis of acute myocardial infarction.
Easy To Use Testing Proceedure
- Two Simple Steps - Add Sample & Reagent Developer
- Colloidal Gold Technology
- Easy-to-read Color Band Signal with Built-in Test Control
- Results in Minutes
- High Sensitivity & Specificity
- No Additional Instrumentation Required
- For In Vitro Diagnostic Use Only
Catalog Number: 85226400115
Kit Sizes: 25, 50 tests
In Stock: Inquire
Availability: Subject to Order Confirmation
| Next > |
|---|